Skip to main content

Journal Club - April 1, 2021

Once-Weekly Semaglutide in Adults with Overweight or Obesity

Curtis Williams presented the STEP-1 TRIAL, which is a randomized, placebo controlled clinical trial looking at this use of semaglutide in patients with elevated BMI and without diabetes. This trial was recently published in NEJM.

CCI is an inclusive centre with multidisciplinary membership for all cardiovascular investigators in BC